Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 775304-60-4 | MDL No. : | MFCD09971792 |
Formula : | C16H11FN2O3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | LFJJTHGQRVVGGN-UHFFFAOYSA-N |
M.W : | 298.27 | Pubchem ID : | 11208732 |
Synonyms : |
|
Num. heavy atoms : | 22 |
Num. arom. heavy atoms : | 17 |
Fraction Csp3 : | 0.06 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 6.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 76.41 |
TPSA : | 65.22 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | Yes |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.69 cm/s |
Log Po/w (iLOGP) : | 3.3 |
Log Po/w (XLOGP3) : | 3.42 |
Log Po/w (WLOGP) : | 3.75 |
Log Po/w (MLOGP) : | 3.33 |
Log Po/w (SILICOS-IT) : | 3.71 |
Consensus Log Po/w : | 3.5 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -4.15 |
Solubility : | 0.021 mg/ml ; 0.0000705 mol/l |
Class : | Moderately soluble |
Log S (Ali) : | -4.47 |
Solubility : | 0.0101 mg/ml ; 0.0000339 mol/l |
Class : | Moderately soluble |
Log S (SILICOS-IT) : | -6.25 |
Solubility : | 0.000169 mg/ml ; 0.000000568 mol/l |
Class : | Poorly soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 2.97 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
96% | Stage #1: at 100℃; for 2 h; Heating / reflux Stage #2: With hydrogenchloride In water |
To a solution of 3-[5-(2-Fluoro-phenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid methyl ester (3.3 g, 111 mmol) in THF (40 mL) was added 1.5M aqueous NaOH (10 mL, 14 mmol). The reaction mixture was refluxed for 2 h at 100° C. The organic solvent was removed and the aqueous solution was diluted with water (50 mL), and then acidified with aqueous HCl. The white precipitate was filtered off and the white cake was washed with cold water and then dried using lyophilizer. The desired acid (3.0 g, 96percent yield) was obtained as a white powder with 98percent purity (LC/UV). Melting point 242° C.; IR υ 3000 (Aromatic C-H), 1710 (CO); 1H-NMR (D6-DMSO) δ 8.31 (1H), 8.18 (2H), 8.08 (1H), 7.88 (2H), 7.51 (2H); 13C-NMR (D6-DMSO) δ 172.71, 167.38, 166.48, 161.25, 135.80, 132.24, 131.79, 131.79, 131.08, 130.91, 129.81, 127.76, 125.48, 117.38, 111.70; 19F-NMR (D6-DMSO) δ 109.7. |
96% | Stage #1: With sodium hydroxide; water In tetrahydrofuran at 100℃; for 2 h; Heating / reflux Stage #2: With hydrogenchloride In water |
To a solution of 3-[5-(2-Fluoro-phenyl)-[l,2,4]oxadiazol-3-yl]-benzoic acid methyl ester (3.3g, 11 mmol) in THF (40 mL) was added 1.5M aqueous NaOH (10 mL, 14 mmol). The reaction mixture was refluxed for 2h at 100 °C. The organic solvent was removed and the aqueous solution was diluted with water (50 mL), and then acidified with aqueous HCl. The white precipitate was filtered off and the white cake was washed with cold water and then dried using lyophilizer. The desired acid (3.Og5 96percent yield) was obtained as a white powder with 98percent purity (LC/UV). Melting point 242 °C; IR D 3000 (Aromatic C-H), 1710 (C=O); 1H-NMR (D6-DMSO) δ 8.31 (IH), 8.18 (2H)3 8.08 (IH), 7.88 (2H), 7.51 (2H); 13C- NMR (D6-DMSO) δ 172.71, 167.38, 166.48, 161.25, 135.80, 132.24, 131.79, 131.79, 131.08, 130.91, 129.81, 127.76, 125.48, 117.38, 111.70; 19F-NMR (D6-DMSO) δ 109.7. |
96% | Stage #1: With sodium hydroxide; water In tetrahydrofuran at 100℃; for 2 h; Heating / reflux Stage #2: With hydrogenchloride In water |
To a solution of 3-[5-(2-Fluoro-phenyl)-[l ,2,4]oxadiazol-3-yl]-benzoic acid methyl ester (3.3g, 1 1 mmol) in THF (40 mL) was added 1.5M aqueous NaOH (10 mL, 14 mmol). The reaction mixture was refluxed for 2h at 100 0C. The organic solvent was removed and the aqueous solution was diluted with water (50 mL), and then acidified with aqueous HCl. The white precipitate was filtered off and the white cake was washed with cold water and then dried using lyophilizer. The desired acid (3.0g, 96percent yield) was obtained as a white powder with 98percent purity (LC/UV). Melting point 242 0C; IR 3000 (Aromatic C-H),ATI-2289908vl 25 <n="27"/>1710 (C=O); 1H-NMR (D6-DMSO) δ 8.31 (IH), 8.18 (2H), 8.08 (IH), 7.88 (2H), 7.51 (2H); 13C-NMR (D6-DMSO) δ 172.71, 167.38, 166.48, 161.25, 135.80, 132.24, 131.79, 131.79, 131.08, 130.91, 129.81, 127.76, 125.48, 1 17.38, 1 11.70; 19F-NMR (D6-DMSO) δ 109.7. |
96% | Stage #1: With sodium hydroxide; water In tetrahydrofuran at 100℃; for 2 h; Stage #2: With hydrogenchloride In water |
To a solution of 3-[5-(2-Fluoro-phenyl)-[l ,2,4]oxadiazol-3-yl]-benzoic acid methyl ester (3.3g, 11 mmol) in THF (40 niL) was added 1.5M aqueous NaOH (10 niL, 14 mmol). The reaction mixture was refluxed for 2h at 100 0C. The organic solvent was removed and the aqueous solution was diluted with water (50 mL), and then acidified with aqueous HCl. The white precipitate was filtered off and the white cake was washed with cold water and then dried using lyophilizer. The desired acid (3.Og, 96percent yield) was obtained as a white powder with 98percent purity (LC/UV). Melting point 242 0C; IR D 3000 (Aromatic C-H), 1710 (C=O); 1H-NMR (D6-DMSO) δ 8.31 (IH), 8.18 (2H), 8.08 (IH), 7.88 (2H), 7.51 (2H); 13C-NMR (D6-DMSO) δ 172.71, 167.38, 166.48, 161.25, 135.80, 132.24, 131.79, 131.79, 131.08, 130.91, 129.81, 127.76, 125.48, 117.38, 111.70; 19F-NMR (D6-DMSO) δ 109.7. |
123 mg | With water; sodium hydroxide In ethanol at 20℃; for 3 h; | General procedure: To a solution of methyl ester 13 (228 mg, 0.76 mmol) in EtOH: H2O (3:2, 10 mL) was added crushed NaOH (91 mg, 2.27 mmol) and the solution was stirred at rt for 3h. The volatiles were evaporated under reduced pressure and the residue obtained was acidified with 1N aqueous HCl (pH ~ 4). This solution was then transferred to a separatory funnel and extracted with EtOAc (3 x 20 mL). The combined organic layers were dried Na2SO4 and concentrated under reduced pressure to afford the title acid 14 (123 mg, 54percent) as a white solid. |
3 g | With water; sodium hydroxide In tetrahydrofuran at 100℃; for 2 h; | A solution of 33 g of methyl 3- [5- (2-fluorophenyl) - [1,2,4-oxadiazol-3-yl] -benzoic acid methyl ester was dissolved in 400 mlOf tetrahydrofuran,To this was added 100 ml of a 1.5 M aqueous solution of sodium hydroxide.The reaction mixture was heated at 100 ° C for 2 hours. The solvent was removed under reduced pressure,The aqueous solution was stirred at 5 ° C for 2 hours.The organic solvent was removed, the aqueous solution was diluted with 50 ml of water,Followed by acidification with hydrochloric acid to pH 1. Filter out a white precipitate, wash the filter cake with cold water,And then dried with a freeze drier.To obtain 3. 0 g of 3- [5- (2_ fluorophenyl) - [1,2,4] oxadiazol-3-yl] benzoic acid. (1H), 8.18 (2H), 08.8 (1H), 7.88 (2H), 7.11 (2H). Show that the sample prepared in Preparation Example 1 was incubated with TO2004091502A2 Example 2 prepared ataluren |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
80% | With potassium carbonate In acetone at 20℃; for 24 h; | General procedure: 2 mmol of either amidoxime 1 [30] or 2 [26] were dissolved in acetone (200 mL) in a round-bottomed flask; then, K2CO3 (0.35 g; 2.5 mmol) and the corresponding aroyl chloride (2.5 mmol), were added to the reaction mixture and stirred for 24 h at room temperature. The solvent was removed under vacuum and the residue treated with water and refluxed for 30 min 1,2,4-Oxadiazoles products were obtained by filtration and further purified by chromatography. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
92% | at 5 - 130℃; for 22 h; | 44g of 3-(N-2-Fluorobenzoylcarbamimidoyl)-benzoic acid methyl ester in toluene (500 mL) was refluxed for 4h at 130 °C using Dean-Stark apparatus. The reaction mixture was stirred at 5 °C for 18h. The white precipitate was filtered off and the filtrate was concentrated, crystallized again in toluene. The desired oxadiazole (38g, 92percent yield) was obtained as a white solid with 99percent purity (LC/UV). 1H-NMR (CDCl3) S 8.91 (IH)5 8.38 (IH)3 8.15 (2H), 7.62 (2H)3 7.35 (2H)3 3.95 (3H). |
92% | at 5 - 130℃; for 22 h; Dean-Stark apparatus | 44g of 3-(N-2-Fluorobenzoylcarbamimidoyl)-benzoic acid methyl ester in toluene (500 mL) was refluxed for 4h at 130 0C using Dean-Stark apparatus. The reaction mixture was stirred at 5 0C for 18h. The white precipitate was filtered off and the filtrate was EPO <DP n="22"/>concentrated, crystallized again in toluene. The desired oxadiazole (38g, 92percent yield) was obtained as a white solid with 99percent purity (LC/UV). 1H-NMR (CDCl3) δ 8.91 (IH), 8.38 (IH), 8.15 (2H), 7.62 (2H)3 7.35 (2H), 3.95 (3H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
92% | at 5 - 130℃; for 22 h; Heating / reflux | 44g of 3-(N-2-Fluorobenzoylcarbamimidoyl)-benzoic acid methyl ester in toluene (500 mL) was refluxed for 4h at 130 0C using Dean-Stark apparatus. The reaction mixture was stirred at 5 0C for 18h. The white precipitate was filtered off and the filtrate was concentrated, crystallized again in toluene. The desired oxadiazole (38g, 92percent yield) was obtained as a white solid with 99percent purity (LC/UV). 1H-NMR (CDCl3) δ 8.91 (IH), 8.38 (IH), 8.15 (2H), 7.62 (2H), 7.35 (2H), 3.95 (3H). |
38 g | at 5 - 130℃; for 22 h; Dean-Stark | At 130 ° C with Dean-StarkThe solution was heated to dissolve 44 grams of toluene in 500 ml3- (N-2-fluorobenzoylamidino) -benzoic acid methyl ester for 4 hours.The reaction mixture was stirred at 5 ° C for 18 hours. The white precipitate was filtered off, the filtrate was concentrated,And then crystallized in toluene.To obtain 38 g of methyl 3- [5- (2-fluorophenyl) - [1,2,4-oxadiazol-3-yl] -benzoic acid methyl ester. |
[ 1092400-82-2 ]
3-(5-(Trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzoic acid
Similarity: 0.72
[ 340736-76-7 ]
4-(5-(Trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzoic acid
Similarity: 0.72
[ 1146699-64-0 ]
3-(4-(Bromomethyl)-3-fluorophenyl)-1,2,4-oxadiazole
Similarity: 0.64
[ 96187-53-0 ]
6-Fluoro-2-(2'-fluoro-[1,1'-biphenyl]-4-yl)-3-methylquinoline-4-carboxylic acid
Similarity: 0.56
[ 96201-88-6 ]
Sodium 6-fluoro-2-(2'-fluoro-[1,1'-biphenyl]-4-yl)-3-methylquinoline-4-carboxylate
Similarity: 0.56
[ 1092400-82-2 ]
3-(5-(Trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzoic acid
Similarity: 0.72
[ 340736-76-7 ]
4-(5-(Trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzoic acid
Similarity: 0.72
[ 1146699-64-0 ]
3-(4-(Bromomethyl)-3-fluorophenyl)-1,2,4-oxadiazole
Similarity: 0.64
[ 256956-42-0 ]
3-(4-(Bromomethyl)phenyl)-5-methyl-1,2,4-oxadiazole
Similarity: 0.61
[ 85386-14-7 ]
Ethyl 2-phenylpyrimidine-5-carboxylate
Similarity: 0.53
[ 148516-11-4 ]
Ethyl 2-cyclopropyl-4-(4-fluorophenyl)quinoline-3-carboxylate
Similarity: 0.53
[ 952285-52-8 ]
Methyl 4-amino-2,5-difluorobenzoate
Similarity: 0.52
[ 125568-73-2 ]
Methyl 5-amino-2,4-difluorobenzoate
Similarity: 0.52
[ 1172889-96-1 ]
Methyl 4-carbamimidoylbenzoate acetate
Similarity: 0.51
[ 1092400-82-2 ]
3-(5-(Trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzoic acid
Similarity: 0.72
[ 340736-76-7 ]
4-(5-(Trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzoic acid
Similarity: 0.72
[ 1146699-64-0 ]
3-(4-(Bromomethyl)-3-fluorophenyl)-1,2,4-oxadiazole
Similarity: 0.64
[ 256956-42-0 ]
3-(4-(Bromomethyl)phenyl)-5-methyl-1,2,4-oxadiazole
Similarity: 0.61